CCCCN1CC(=O)N2[C@H]3c4ccccc4OC[C@@H]3[C@H](C(=O)OCC)[C@]2(C)C1=O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?